BiotechTubeBiotechTube
Home/Rohto Pharmaceutical/Takeshi Yoshida
TY

Takeshi Yoshida

Director, Senior Managing Executive Officer

Rohto Pharmaceutical

Therapeutic Areas

OphthalmologyDermatologyGastroenterologyMetabolic DiseaseConsumer Health

Rohto Pharmaceutical Pipeline

DrugIndicationPhase
DE-130 (Etrasimod)Ulcerative ColitisPhase 3
DE-126 (Finerenone)Diabetic Kidney Disease / Chronic Kidney Disease with Type 2 DiabetesFiled
DE-122 (Carotegrast methyl)Ulcerative ColitisPhase 3
DE-120 (Ciclosporin ophthalmic gel)Dry Eye DiseasePhase 3
RV-001Retinal Diseases (e.g., AMD, DR)Preclinical
Rohto Zi: / Rohto C Cube:Eye Fatigue, Dry Eye, Allergic ConjunctivitisCommercial
Hada LaboSkin Moisturization & CareCommercial

Leadership Team at Rohto Pharmaceutical

MS
Masashi Sugimoto
Representative Director, President & CEO
HY
Hiroshi Yamaguchi
Director, Senior Managing Executive Officer
KA
Kazunori Araki
Director, Managing Executive Officer
YO
Yasuhiko Oshima
Director, Managing Executive Officer
SO
Shinji Oshima
Director
YO
Yoshihiro Oka
Director
YK
Yoshiko Kita
Director
YI
Yoshimi Ichikawa
Director
TK
Takashi Kondo
Corporate Auditor
YI
Yoshihisa Inoue
Corporate Auditor
View full Rohto Pharmaceutical profile